CerS6 links ceramide metabolism to innate immune responses in diabetic kidney disease

Zijing Zhu, Yun Cao, Yonghong Jian, Hongtu Hu, Qian Yang, Yiqun Hao, Houhui Jiang, Zilv Luo, Xueyan Yang, Weiwei Li, Jijia Hu, Hongyan Liu, Wei Liang, Guohua Ding () and Zhaowei Chen ()
Additional contact information
Zijing Zhu: Renmin Hospital of Wuhan University
Yun Cao: Renmin Hospital of Wuhan University
Yonghong Jian: Renmin Hospital of Wuhan University
Hongtu Hu: Renmin Hospital of Wuhan University
Qian Yang: Renmin Hospital of Wuhan University
Yiqun Hao: Renmin Hospital of Wuhan University
Houhui Jiang: Renmin Hospital of Wuhan University
Zilv Luo: Renmin Hospital of Wuhan University
Xueyan Yang: Renmin Hospital of Wuhan University
Weiwei Li: Renmin Hospital of Wuhan University
Jijia Hu: Renmin Hospital of Wuhan University
Hongyan Liu: Renmin Hospital of Wuhan University
Wei Liang: Renmin Hospital of Wuhan University
Guohua Ding: Renmin Hospital of Wuhan University
Zhaowei Chen: Renmin Hospital of Wuhan University

Nature Communications, 2025, vol. 16, issue 1, 1-20

Abstract: Abstract Ectopic lipid deposition, mitochondrial injury, and inflammatory responses contribute to the development of diabetic kidney disease (DKD); however, the mechanistic link between these processes remains unclear. In this study, we demonstrate that the ceramide synthase 6 (CerS6) is primarily localized in podocytes of the glomeruli and is upregulated in two different models of diabetic mice. Podocyte-specific CerS6 knockout ameliorates glomerular injury and inflammatory responses in male diabetic mice and in male mice with adriamycin-induced nephropathy. In contrast, podocyte-specific overexpression of CerS6 sufficiently induces proteinuria. Mechanistically, CerS6-derived ceramide (d18:1/16:0) can bind to the mitochondrial channel protein VDAC1 at Glu59 residue, initiating mitochondrial DNA (mtDNA) leakage, activating the cGAS-STING signaling pathway, and ultimately promoting an immune-inflammatory response in the kidney. Importantly, CERS6 expression is increased in podocytes from kidney biopsies of patients with DKD and focal segmental glomerulosclerosis (FSGS), and the expression level of CERS6 is correlated negatively with glomerular filtration rate and positively with proteinuria. Thus, our findings suggest that targeting CerS6 may be a potential therapeutic strategy for proteinuric kidney diseases.

Date: 2025
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-025-56891-x Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-56891-x

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-025-56891-x

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().